The Genetics Podcast

Precision Pioneers EP 5: Alnylam's Josh Friedman on developing precision medicines for the 'silent killer' NASH/NAFLD

May 5th, 2021  •  34 mins 28 secs  •  Download (23.7 MB)  •  Link with Timestamp

RSS Feed

On this episode of the podcast, Patrick is joined by Josh Friedman, Senior Director of Research at Alnylam Pharmaceuticals.